Literature DB >> 30227941

Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis.

Juhwan Lee1, Rine Nakanishi1, Dong Li1, Kashif Shaikh1, Chandana Shekar1, Kazuhiro Osawa1, Negin Nezarat1, Eranthi Jayawardena1, Maja Blanco1, Matthew Chen1, Matthew Sieckert1, Eric Nelson1, Darius Billingsley1, Sajad Hamal1, Matthew J Budoff2.   

Abstract

Warfarin, a vitamin K antagonist, is associated with systemic vascular calcification. We evaluated whether rivaroxaban (a direct oral factor Xa inhibitor with no interaction with vitamin K) will slow the progression in coronary plaque volumes compared with warfarin in patients with nonvalvular atrial fibrillation using coronary computed tomography angiography.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30227941     DOI： 10.1016/j.ahj.2018.08.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  A review of serial coronary computed tomography angiography (CTA) to assess plaque progression and therapeutic effect of anti-atherosclerotic drugs.

Authors:  Jana Taron; Saeyun Lee; John Aluru; Udo Hoffmann; Michael T Lu
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-19       Impact factor: 2.357

2.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis.

Authors:  Romeo Gabriel Mihaila
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-02-18       Impact factor: 1.245

4.  Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II.

Authors:  Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-03-22       Impact factor: 9.130

Review 5.  Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.

Authors:  Jin Sug Kim; Hyeon Seok Hwang
Journal:  Korean Circ J       Date:  2021-12       Impact factor: 3.243

6.  Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis.

Authors:  Nina D Kosciuszek; Daniel Kalta; Mohnish Singh; Olga V Savinova
Journal:  Front Cardiovasc Med       Date:  2022-08-19

7.  Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.

Authors:  Matthew J Budoff; Deepak L Bhatt; April Kinninger; Suvasini Lakshmanan; Joseph B Muhlestein; Viet T Le; Heidi T May; Kashif Shaikh; Chandana Shekar; Sion K Roy; John Tayek; John R Nelson
Journal:  Eur Heart J       Date:  2020-10-21       Impact factor: 29.983

8.  Extent of arterial calcification by conventional vitamin K antagonist treatment.

Authors:  Selma Hasific; Kristian Altern Øvrehus; Oke Gerke; Jesper Hallas; Martin Busk; Jess Lambrechtsen; Grazina Urbonaviciene; Niels Peter Rønnow Sand; Jens Steen Nielsen; Louise Diederichsen; Kenneth Bruun Pedersen; Rasmus Carter-Storch; Nivethitha Ilangkovan; Hans Mickley; Lars Melholt Rasmussen; Jes Sandal Lindholt; Axel Diederichsen
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

Review 9.  The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review.

Authors:  Kalaimani Elango; Awad Javaid; Banveet K Khetarpal; Sathishkumar Ramalingam; Krishna Prasad Kolandaivel; Kulothungan Gunasekaran; Chowdhury Ahsan
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

10.  Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.

Authors:  Robert Stöhr; Timm Dirrichs; Kinan Kneizeh; Sebastian Reinartz; Dario Frank; Johannes Brachmann; Joerg Schroeder; Leon Schurgers; Claudia Göttsch; Andras Keszei; Jürgen Floege; Nikolaus Marx; Vincent Brandenburg; Alexander Schuh
Journal:  Clin Cardiol       Date:  2022-03-25       Impact factor: 3.287
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.